AstraZeneca (AZN)
(Delayed Data from NSDQ)
$77.54 USD
+0.67 (0.87%)
Updated Sep 25, 2024 04:00 PM ET
After-Market: $77.51 -0.03 (-0.04%) 7:58 PM ET
2-Buy of 5 2
B Value D Growth F Momentum D VGM
Earnings News For AZN
-
AstraZeneca (AZN) Beats on Q2 Earnings & Sales, Ups '24 View
-
Astrazeneca: Q2 Earnings Snapshot
-
AstraZeneca (AZN) Q1 Earnings & Sales Beat Estimates, Stock Up
-
Astrazeneca: Q1 Earnings Snapshot
-
AstraZeneca (AZN) to Report Q1 Earnings: Here's What to Expect
-
AstraZeneca (AZN) Q4 Earnings & Sales Miss Estimates, Stock Down
-
Astrazeneca: Q4 Earnings Snapshot
-
AstraZeneca (AZN) to Report Q4 Earnings: Here's What to Expect
-
AstraZeneca (AZN) Beats on Q3 Earnings & Sales, Ups 2023 View
-
Astrazeneca: Q3 Earnings Snapshot
-
AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?
-
AstraZeneca (AZN) Q2 Earnings & Sales Beat, Nil COVID Sales
-
Astrazeneca: Q2 Earnings Snapshot
-
AstraZeneca (AZN) to Report Q2 Earnings: What's in the Cards?
-
AstraZeneca (AZN) Q1 Earnings Beat, COVID Products Hurt Sales
-
Astrazeneca: Q1 Earnings Snapshot
-
AstraZeneca (AZN) to Report Q1 Earnings: What's in the Cards?
-
AstraZeneca (AZN) Q4 Earnings Beat, Sales Hurt by COVID Jab
-
Astrazeneca: Q4 Earnings Snapshot
-
AstraZeneca (AZN) to Report Q4 Earnings: What's in the Cards?
-
AstraZeneca's (AZN) Q3 Earnings Beat, EPS Growth View Up
-
Astrazeneca: Q3 Earnings Snapshot
-
AstraZeneca (AZN) to Report Q3 Earnings: What's in the Cards?
-
AstraZeneca (AZN) Beats on Q2 Earnings, Ups Sales Growth View
-
Astrazeneca: Q2 Earnings Snapshot